List of Tables
    Table 1. Opioids Agonist Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Opioids Agonist Drugs Market Trends
    Table 3. Opioids Agonist Drugs Market Drivers
    Table 4. Opioids Agonist Drugs Market Challenges
    Table 5. Opioids Agonist Drugs Market Restraints
    Table 6. Global Opioids Agonist Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Opioids Agonist Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Opioids Agonist Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Opioids Agonist Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Opioids Agonist Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Opioids Agonist Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Opioids Agonist Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Opioids Agonist Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Opioids Agonist Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Opioids Agonist Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Opioids Agonist Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Opioids Agonist Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2021)
    Table 18. Top Players of Opioids Agonist Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Opioids Agonist Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Opioids Agonist Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Opioids Agonist Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Opioids Agonist Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Opioids Agonist Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Opioids Agonist Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Opioids Agonist Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Opioids Agonist Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Opioids Agonist Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Opioids Agonist Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Opioids Agonist Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Opioids Agonist Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Opioids Agonist Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Opioids Agonist Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Opioids Agonist Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Opioids Agonist Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Opioids Agonist Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Opioids Agonist Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Opioids Agonist Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Opioids Agonist Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Opioids Agonist Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Opioids Agonist Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Purdue Pharma Corporation Information
    Table 43. Purdue Pharma Description and Business Overview
    Table 44. Purdue Pharma Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Purdue Pharma Opioids Agonist Drugs Product
    Table 46. Purdue Pharma Recent Development
    Table 47. Titan pharmaceuticals Corporation Information
    Table 48. Titan pharmaceuticals Description and Business Overview
    Table 49. Titan pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Titan pharmaceuticals Product
    Table 51. Titan pharmaceuticals Recent Development
    Table 52. Boehringer Ingelheim Corporation Information
    Table 53. Boehringer Ingelheim Description and Business Overview
    Table 54. Boehringer Ingelheim Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Boehringer Ingelheim Product
    Table 56. Boehringer Ingelheim Recent Development
    Table 57. Janssen Pharmaceuticals, Inc Corporation Information
    Table 58. Janssen Pharmaceuticals, Inc Description and Business Overview
    Table 59. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Janssen Pharmaceuticals, Inc Product
    Table 61. Janssen Pharmaceuticals, Inc Recent Development
    Table 62. Sanofi Corporation Information
    Table 63. Sanofi Description and Business Overview
    Table 64. Sanofi Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Sanofi Product
    Table 66. Sanofi Recent Development
    Table 67. Sun Pharmaceuticals Corporation Information
    Table 68. Sun Pharmaceuticals Description and Business Overview
    Table 69. Sun Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Sun Pharmaceuticals Product
    Table 71. Sun Pharmaceuticals Recent Development
    Table 72. Mallinckrodt Pharmaceuticals Corporation Information
    Table 73. Mallinckrodt Pharmaceuticals Description and Business Overview
    Table 74. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Mallinckrodt Pharmaceuticals Product
    Table 76. Mallinckrodt Pharmaceuticals Recent Development
    Table 77. Egalet Corporation Corporation Information
    Table 78. Egalet Corporation Description and Business Overview
    Table 79. Egalet Corporation Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Egalet Corporation Product
    Table 81. Egalet Corporation Recent Development
    Table 82. Endo Pharmaceuticals Inc. Corporation Information
    Table 83. Endo Pharmaceuticals Inc. Description and Business Overview
    Table 84. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Endo Pharmaceuticals Inc. Product
    Table 86. Endo Pharmaceuticals Inc. Recent Development
    Table 87. Allergan, Plc Corporation Information
    Table 88. Allergan, Plc Description and Business Overview
    Table 89. Allergan, Plc Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Allergan, Plc Product
    Table 91. Allergan, Plc Recent Development
    Table 92. Pfizer Inc Corporation Information
    Table 93. Pfizer Inc Description and Business Overview
    Table 94. Pfizer Inc Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Pfizer Inc Product
    Table 96. Pfizer Inc Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Opioids Agonist Drugs Customers List
    Table 100. Opioids Agonist Drugs Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Opioids Agonist Drugs Product Picture
    Figure 2. Global Opioids Agonist Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Opioids Agonist Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Opioids Agonist Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Opioids Agonist Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Opioids Agonist Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Opioids Agonist Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Opioids Agonist Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Opioids Agonist Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Opioids Agonist Drugs Report Years Considered
    Figure 11. Product Picture of Codeine
    Figure 12. Product Picture of Fentanyl
    Figure 13. Product Picture of Meperidine
    Figure 14. Product Picture of Methadone
    Figure 15. Product Picture of Morphine
    Figure 16. Product Picture of Hydrocodone
    Figure 17. Global Opioids Agonist Drugs Market Share by Type in 2022 & 2028
    Figure 18. Global Opioids Agonist Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 19. Global Opioids Agonist Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 20. Global Opioids Agonist Drugs Sales by Type (2017-2028) & (K Units)
    Figure 21. Global Opioids Agonist Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 22. Global Opioids Agonist Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 23. United States Opioids Agonist Drugs Market Share by Type in 2022 & 2028
    Figure 24. United States Opioids Agonist Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 25. United States Opioids Agonist Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 26. United States Opioids Agonist Drugs Sales by Type (2017-2028) & (K Units)
    Figure 27. United States Opioids Agonist Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 28. United States Opioids Agonist Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 29. Product Picture of Pain Management
    Figure 30. Product Picture of Cough Treatment
    Figure 31. Product Picture of Diarrhea Treatment
    Figure 32. Global Opioids Agonist Drugs Market Share by Application in 2022 & 2028
    Figure 33. Global Opioids Agonist Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 34. Global Opioids Agonist Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 35. Global Opioids Agonist Drugs Sales by Application (2017-2028) & (K Units)
    Figure 36. Global Opioids Agonist Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 37. Global Opioids Agonist Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 38. United States Opioids Agonist Drugs Market Share by Application in 2022 & 2028
    Figure 39. United States Opioids Agonist Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 40. United States Opioids Agonist Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 41. United States Opioids Agonist Drugs Sales by Application (2017-2028) & (K Units)
    Figure 42. United States Opioids Agonist Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 43. United States Opioids Agonist Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 44. North America Opioids Agonist Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. North America Opioids Agonist Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. U.S. Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Canada Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Europe Opioids Agonist Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 49. Europe Opioids Agonist Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 50. Germany Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. France Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.K. Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Italy Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Russia Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Asia-Pacific Opioids Agonist Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 56. Asia-Pacific Opioids Agonist Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 57. China Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Japan Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. South Korea Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. India Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Australia Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Taiwan Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Indonesia Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Thailand Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Malaysia Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Philippines Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Latin America Opioids Agonist Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Latin America Opioids Agonist Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Mexico Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Brazil Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Argentina Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Middle East & Africa Opioids Agonist Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 73. Middle East & Africa Opioids Agonist Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 74. Turkey Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Saudi Arabia Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. U.A.E Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. Opioids Agonist Drugs Value Chain
    Figure 78. Opioids Agonist Drugs Production Process
    Figure 79. Channels of Distribution
    Figure 80. Distributors Profiles
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed